These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26699426)

  • 21. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
    Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
    J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors.
    Song F; Sakurai N; Okamoto A; Koide H; Oku N; Dewa T; Asai T
    Biol Pharm Bull; 2019; 42(6):996-1003. PubMed ID: 31155597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics.
    Bruniaux J; Djemaa SB; Hervé-Aubert K; Marchais H; Chourpa I; David S
    Int J Pharm; 2017 Nov; 532(2):660-668. PubMed ID: 28506802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice.
    Wang XL; Xu R; Wu X; Gillespie D; Jensen R; Lu ZR
    Mol Pharm; 2009; 6(3):738-46. PubMed ID: 19296675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting hepatic gluconeogenesis by chitosan lactate nanoparticles containing CRTC2 siRNA targeted by poly(ethylene glycol)-glycyrrhetinic acid.
    Rastegari A; Mottaghitalab F; Dinarvand R; Amini M; Arefian E; Gholami M; Atyabi F
    Drug Deliv Transl Res; 2019 Jun; 9(3):694-706. PubMed ID: 30825078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of PEG Chain Length on the Physical Properties and Bioactivity of PEGylated Chitosan/siRNA Nanoparticles in Vitro and in Vivo.
    Yang C; Gao S; Dagnæs-Hansen F; Jakobsen M; Kjems J
    ACS Appl Mater Interfaces; 2017 Apr; 9(14):12203-12216. PubMed ID: 28332829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA.
    Noh SM; Park MO; Shim G; Han SE; Lee HY; Huh JH; Kim MS; Choi JJ; Kim K; Kwon IC; Kim JS; Baek KH; Oh YK
    J Control Release; 2010 Jul; 145(2):159-64. PubMed ID: 20385182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.
    Malhotra M; Tomaro-Duchesneau C; Saha S; Kahouli I; Prakash S
    Int J Nanomedicine; 2013; 8():2041-52. PubMed ID: 23723699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability.
    Godinho BM; Ogier JR; Quinlan A; Darcy R; Griffin BT; Cryan JF; O'Driscoll CM
    Int J Pharm; 2014 Oct; 473(1-2):105-12. PubMed ID: 24992319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
    Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
    Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.
    Lo JH; Kwon EJ; Zhang AQ; Singhal P; Bhatia SN
    Bioconjug Chem; 2016 Oct; 27(10):2323-2331. PubMed ID: 27583545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
    Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
    J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.